Initial results and long-term clinical follow-up of an amorphous hydrogenated silicon-carbide-coated stent in daily practice

International Journal of Cardiovascular Interventions

Volumn 1, Issue 2, 1998, Pages 81-85

  Hanekamp, Clara ee ^a   Bonnier, Hans Jrm ^a   Michels, Rolf h ^a   Peels, Kathinka h ^a   Heijmen, Eric Pcm ^a   Hagen, Eduard Van ^a   Koolen, jacques j ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Restenosis; Silicon Carbide; Stent; Stent Coating

Indexed keywords

EID: 11944265766     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/acc.1.2.81.85     Document Type: Article

References (16)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberg L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Eng J Med 1987; 316: 701-706.
2. von Birgelen C, Gil R, Ruygrok P, et al. Optimised expansion of the wallstent compared with the Palmaz Schatz stent: on line observations with two and three dimensional intracoronary ultrasound after angiographic guidance. Am Heart J 1996; 131: 1067-1075.
3. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
4. Schomig A, Neumann FJ, Kastrati A, et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Eng J Med 1996; 334: 1084-1089.
5. Fischman DL, Leon MB, Baim DS, et al. A randomised comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Eng J Med 1994; 331: 496-501.
6. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group. N Eng J Med 1994 25; 331: 489-495.
7. Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon expandable Palmaz Schatz stent. J Am Coll Cardiol 1993; 21: 26-34.
8. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Eng J Med 1987; 316: 1371-1375.
9. Liu MW, Voorhees WD III, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for the threatened or acute closure complicating coronary balloon angioplasty: a Cook registry study. Am Heart J 1995; 130: 8-13.
10. Schaldach M et al. Artificial Heart Valves: improved blood compatibility by PaCVD silicon-carbide coating. Biotronik Rev 1989; 9: 1-8.
11. Van Oeveren W, Tigchelaar I, Monnink SHJ, van Luyn MJA, Haan J. Biocompatibility of Biotronik Tensum 3 stents. Submitted for publication.
12. Reiber JHC, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium- and long-term variations in arterial dimensions from computer assisted quantification of coronary cine-angiograms. Circulation 1985; 71: 280-288.
13. Haase J, DiMario C, Slager CJ, et al. In vivo validation of online and off-line geometric coronary measurements using insertion of stenosis phantom in porcine coronary arteries. Cathet Cardiovasc Diagn 1992; 27: 16-27.
14. Tilli FV, Aliabadi D, Kinn JW, Kaplan BM, Benzuly KH, Safian R. Real life stenting: a Comparison of target vessel revascularization in Benestent-Stress lesions to Non Benestent-Stress lesions (Abstr). Circulation 1996; 94: I-332.
15. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB III, Gruntzig AR. In hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985; 72: 1044-1052.
16. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-527.